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INTRODUCTION 
 
Aortic stenosis (AS) continues to be an important valvular heart disease that leads 
to significant morbidity and mortality. The natural history of aortic stenosis is limited by 
onset of left ventricular systolic dysfunction. Nowadays the importance of identifying 
diastolic dysfunction in patients with aortic stenosis is being recognized since it 
contributes significantly to the onset of symptoms and prognosis1.  
Left ventricular (LV) hypertrophy is an adaptive process that compensates for 
pressure overload associated with aortic stenosis and is responsible for changes in 
systolic and diastolic functions2-4. This process is accompanied by a remodeling of the 
LV that involves the muscular and non muscular compartments of the ventricle. As a 
result of this remodeling process, muscle fiber hypertrophy and abnormalities of the 
collagen network occur that are responsible for changes in systolic and diastolic 
functions5,6.  
Although it has been previously shown that aortic valve replacement may lead to 
immediate hemodynamic improvement and to prolongation of survival7, it has been 
reported that regression of myocardial hypertrophy after relief of the hemodynamic 
burden is a process that may continue for decades after valve replacement2. However, 
abnormal exercise hemodynamics may persist late after valve replacement despite a 
normal systolic function, suggesting impaired diastolic function in these patients.                  
LV systolic function may be normal in the presence of advanced diastolic 
dysfunction in aortic stenosis. Patients with aortic stenosis develop variable grades of 
diastolic dysfunction even before the onset of symptoms7.             
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Changes in the structures within the extracellular matrix (ECM) can also affect 
diastolic function. The myocardial ECM is composed of 3 important constituents:    
                      (1) fibrillar protein, such as collagen type I, collagen type III, and elastin;   
                      (2) proteoglycans;  
                      (3) basement membrane proteins, such as collagen type IV, laminin, and 
fibronectin 
           It has been hypothesized that the most important component within the ECM that 
contributes to the development of diastolic heart failure is fibrillar collagen. The evidence 
that suggests that changes in ECM fibrillar collagen play an important role in the 
development of diastolic dysfunction and diastolic heart failure in the following three 
ways11-15. 
First, disease processes that alter diastolic function also alter ECM fibrillar 
collagen, particularly in terms of its amount, geometry, distribution, degree of 
crosslinking, and ratio of collagen type I versus collagen type III. 
            Second, treatment of these disease processes, which is successful in correcting 
diastolic function, is associated with normalization of fibrillar collagen.  
            Third, experiments in which a chronic alteration in collagen metabolism is 
accomplished result in an alteration of diastolic function16-21. The role played by other 
fibrillar proteins, the basement membrane proteins, and the proteoglycans remains largely 
unexplored. 
 Whether to perform valve replacement in patients with asymptomatic, but severe 
aortic stenosis is controversial. Physician usually reluctant to refer patients with 
severe aortic stenosis for valve replacement as long as they remain asymptomatic.   
However, there remains concern about the risk of irreversible myocardial damage or 
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sudden death among such patients who do not undergo surgery. In contrast to 
patients with valvular regurgitation, patients with severe aortic stenosis who are still 
asymptomatic but already have impaired left ventricular function are very rare. 
            Once severe degrees of diastolic dysfunction develop in the pre operative period, 
patients will be persistently symptomatic even after aortic valve replacement. These 
patients also have increased short and long term mortality. This is due to persistence of 
left ventricular diastolic dysfunction in those patients which results in increased 
morbidity and mortality. 
            So, it is very important to identify the patients with aortic stenosis and normal LV 
function, before they develop higher grades of LV diastolic dysfunction. They should 
undergo aortic valve replacement eventhough their systolic function is normal. 
According to ACC/AHA 2006 ( American college of cardiology / American heart 
association ) guidelines for operability in valvular heart disease, class 1 indication for 
isolated aortic valve replacement in patients with severe aortic stenosis and normal LV 
systolic function is the presence of symptoms22. So, in this study our aim is to find out an 
echocardiographic diastolic index which correlates with LV diastolic dysfunction and 
symptoms. 
 In this study to test the functional capacity and the severity of symptoms six 
minute walk test (6MWT) was performed. The strongest indication for the 6MWT is for 
measuring the response to medical interventions in patients with moderate to severe heart 
or lung disease. The 6MWT has also been used as a one-time measure of functional status 
of patients, as well as a predictor of morbidity and mortality. 
            Echocardiography has been and continues to be the most commonly used and 
most readily available investigation modality for the assessment of diastolic dysfunction. 
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Various echo parameters have been in use, like the early and late transmitral filling 
velocities ( E & A ), deceleration time of E slope, isovolumic relaxation time, pulmonary 
vein systolic and diastolic velocities, pulmonary vein atrial flow reversal velocity and  
duration etc. Each of them lacks sensitivity and specificity when applied individually; 
they have their own drawbacks, and even the combination of various parameters always 
can not give a better and more accurate estimate of diastolic dysfunction. Even routine 
grading of diastolic dysfunction also has limitation in differentiating  
1. Pseudo normal and normal patterns 
2. Grade 3 and grade 4 diastolic dysfunctions,  
and most of the times it needs tissue doppler imaging to differentiate them. 
            Tissue Doppler derived indices like Ea and E/Ea may be used to identify the 
presence and severity of diastolic dysfunction. E/Ea value of more than fifteen correlates 
with pulmonary capillary pressure of more than 20 mmHg. In the presence of severe LV 
systolic dysfunction, increased E value and DT of less than 130 msec both correlate to 
elevated PCWP. But with normal LV systolic function both lose their correlation to 
PCWP. E/Ea value is not modified by the presence of LV systolic dysfunction. E/Ea is 
preload, afterload and heart rate independent index. So, it is more reliable even in 
circumstances which modify the above factors.     
Apart from these, other methods available for measuring diastolic dysfunction are 
cardiac catheterization and magnetic resonance imaging (MRI). Cardiac catheterization 
has limitation in the form of being invasive and cumbersome calculations. MRI has 
limited availability and being costlier. Echocardiography will continue to be the first line 
investigation of choice for the assessment of diastolic dysfunction for the time to come.                                  
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                                                        AIM OF THE STUDY 
 
¾ To find out the tissue doppler derived E/Ea values in patients with moderate and 
severe aortic stenosis. 
¾ To assess the presence of diastolic dysfunction in patients with aortic stenosis. 
¾ To find out the relationship between the E/Ea values and presence of symptoms in 
patients with AS. 
¾ To correlate the six minute walk distance to E/Ea values in patients with moderate 
and severe AS. 
¾ To find out the relationship between various diastolic indices and symptoms in 
patients with AS 
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                                            REVIEW OF LITERATURE 
 
Etiology and pathogenesis of aortic stenosis: 
Valvular heart disease continues to be an important threat to human community 
across all part of the world. Valvular aortic stenosis accounts for almost two thirds of 
aortic valve replacements done recently. Obstruction to left ventricular outflow may 
occur at the valvular, sub valvular and supra valvular levels. Left ventricular out flow 
obstruction commonly at the level of aortic valve (valvular AS) is being studied in this 
thesis. 
Valvular AS has three principal causes; 
1. Degenerative (calcific) 
2. Rheumatic etiology 
3. Congenital bicuspid aortic valve stenosis (BCAV) 
Other rare causes of aortic stenosis include atherosclerosis, severe hyper 
cholesterolemia, rheumatoid arthritis, ochronosis and alkaptonuria. 
Congenital aortic stenosis; 
 Congenital malformations of aortic valve may be unicuspid, bicuspid, tricuspid 
and dome shaped valve stenosis. Unicuspid valve produces severe obstruction in infancy 
and is the cause for most of the fatal aortic stenosis under one year of age. Bicuspid aortic 
valve is more frequent in men than in women with ratio being 4:1. It is transmitted in 
autosomal dominant pattern23,24. A mutation in NOTCH1 gene has been described as the 
cause for bicuspid aortic valve25.  
 A bicuspid aortic valve normally functions in childhood. Most of the patients with 
BCAV develop severe aortic stenosis in later in adulthood. They typically present with 
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severe AS above the age of fifty years. They have associated medial abnormality and 
present with post stenotic dilatation of ascending aorta. Although the histopathology of 
BCAV with aortic stenosis is no different than that of tricuspid aortic valve stenosis, the 
turbulent flow and leaflet stress cause the BCAV to present earlier with stenosis than 
tricuspid aortic valve. 
Calcific aortic stenosis: 
 Age related calcific AS of tricuspid and bicuspid aortic valve has emerged as the 
most important cause of aortic stenosis in elderly. Calcific AS was formerly termed as 
senile or degenerative AS. Above 65 years of age 2% of general population have severe 
calcific AS and nearly 29% have age related sclerosis of the aortic valve without stenosis. 
Patients with calcific valve disease irrespective of the degree of obstruction have 50% 
increased mortality from coronary artery disease and cardiovascular deaths26-28. 
 The risk factor for development of calcific AS is the same as for atherosclerosis 
like elevated serum levels of LDL cholesterol, diabetes mellitus, smoking and 
hypertension. Calcific AS also linked to inflammatory markers and components of 
metabolic syndrome. Retrospective studies have proved that treatment with statins 
reduces the progression of calcific AS and this effect has been demonstrated in animal 
models.  
Rheumatic aortic stenosis: 
 Rheumatic heart disease most commonly affects mitral valve in the form of either 
stenosis or regurgitation. Aortic valve involvement in rheumatic etiology is most often 
associated with mitral valve involvement. Only a less number of patients have isolated 
aortic valve involvement in rheumatic heart disease.  
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Rheumatic AS results from fusion of commisures and cusps. There is also 
revascularization of leaflets of valve ring. This leads to stiffening of the free borders of 
the cusps. Calcific nodules develop on both side of the cusps and the orifice is reduced 
small triangular or round opening. As a consequence the rheumatic valve is often 
regurgitant as well as stenotic. With the decline in rheumatic fever, the incidence of 
rheumatic AS declines in western part of the world; it remains to be an important 
problem worldwide. 
                                     NORMAL AORTIC VALVE 
                                                                                                  
          Figure1; Normal aortic valve showing three leaflets, there is no calcification 
 
                                          DEGENERATIVE AORTIC STENOSIS 
                                 
 
 
 
 
 
            Figure 2; Degenerative AS showing thickened and heavily calcified leaflets 
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Pathophysiology of aortic stenosis: 
 In adults with AS, the severity of stenosis develops over prolonged period. Left 
ventricular systolic function is well maintained in patients with AS because the left 
ventricle (LV) adapts to slowly developing increase in wall stress. Even in patients with 
severe AS the cardiac output is maintained by the presence of severe LV hypertrophy. 
The presence of LV hypertrophy which sustain a large pressure gradient across the aortic 
valve for many years with out reduction in cardiac output, LV dilatation, or the 
development of symptoms. 
 According to ACC/ AHA guideline for valvular heart disease in 2006, severe AS 
is defined as  
1. Peak velocity across the aortic valve more than 4 m/sec  
2. Mean gradient across the aortic valve of more than 40 mmHg.  
3. Aortic orifice by continuity equation, less than 1cm2  (0.6cm2 / m2 body 
surface area) 
4. Left ventricular outflow tract TVI / Aortic valve TVI ≤ 0.25 (TVI-time 
velocity integral) 
Moderate aortic stenosis is defined as, 
1. Peak velocity across the aortic valve between 3 and 4 m/sec 
2. Mean gradient across the aortic valve between 25 and 40 mmHg 
3. Aortic valve orifice between 1 and 1.5 cm2  
However the degree of stenosis associated with symptom onset varies between 
patients and there is no single number that defines the severe or critical AS in an 
individual patient. Clinical decisions are based on the consideration of symptom status 
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and the LV response to chronic pressure overload, in conjunction with hemodynamic 
severity.  
 Chronic pressure overload typically results in concentric LV hypertrophy with 
increased wall thickness and a normal chamber size. The increased wall thickness allows 
normalization of wall stress (afterload) so that LV contraction is maintained. However 
increased cell mass and interstitial matrix results in development of diastolic dysfunction, 
which may persist even after the relief of AS. Gender differences in LV performances in 
patients with aortic stenosis have been demonstrated; with women more frequently have 
normal LV performance with smaller, thick walled, concentrically hypertrophied LV with 
diastolic dysfunction with normal or even subnormal systolic wall stress. Men more 
frequently have eccentric left ventricular hypertrophy, excessive wall stress, systolic 
dysfunction and chamber dilation. 
 The ventricular changes caused by chronic pressure overload and reflected in left 
ventricular and left atrial pressure wave forms and in Doppler velocity curves. As the 
contraction of the left ventricle becomes progressively more isometric, the Doppler 
velocity curve exhibits a progressively later systolic peak. The elevated left ventricular 
end diastolic pressure and corresponding changes in doppler filling velocities which are 
characteristic of severe AS, reflects delayed relaxation and eventually decreased 
compliance of hypertrophied left ventricular wall. In patients with severe AS large a 
waves appear in left atrial pressure pulse and in Doppler left ventricular filling curve 
because of the combination of enhanced contraction of the hypertrophied left atrium and 
diminished left ventricular compliance. 
 Atrial contraction plays an important role in filling of left ventricle in AS. It 
increases left ventricular end diastolic pressure with elevation of mean left atrial pressure. 
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This booster pump function of left atrial contraction helps from prevention of developing 
pulmonary congestion, while at the time maintaining LV end diastolic pressure at the 
level to produce adequate cardiac output. Loss of atrial contraction as in atrial fibrillation 
or inappropriately timed atrial contraction as in atrioventricular dissociation leads to rapid 
clinical deterioration in patients with aortic stenosis.  
 Systemic vascular resistance also contributes to left ventricular afterload in 
patients with AS. Concurrent hypertension may affect the evaluation of severity of AS. 
Exercise physiology is altered in patients with moderate to severe AS and even 
asymptomatic patients will have reduced exercise tolerance. Although cardiac output is 
normal at rest, there is blunted response to exercise induced increase in cardiac output 
and mediated primarily by increase in heart rate with little change in stroke volume.  
 Even though the stroke volume is unchanged, transvalvular flow rate increases 
due to shortened systolic ejection time so that aortic jet velocity and transvalvular 
gradient increase proportionately. There will be small increase valve area during exercise 
in patients with AS, but when severity increases the valve area becomes fixed, resulting 
in greater jet velocity and gradient. At this point there is an abnormal blood pressure 
response to exercise in the form of fall or failure to rise in systolic blood pressure more 
than 10 mmHg, signifying severe AS.              
Myocardial function in aortic stenosis: 
The development of left ventricular hypertrophy is the one of the important 
mechanism by which left ventricle adapts to increased hemodynamic burden. The 
increased wall stress leads to increase in number of sarcomeres in parallel and leads to 
concentric hypertrophy. The increase in wall thickness is important in counterbalancing 
increase in systolic wall stress, as the AS develops slowly the wall stress remains normal. 
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In some patients inadequate wall thickening results in dilatation of LV cavity and left 
ventricular failure. This is called as afterload mismatch. There is true depression of left 
ventricular systolic function. In this group surgery is less effective.  
Diastolic properties in patients with aortic stenosis: 
 Although left ventricular hypertrophy is a key adoptive mechanism in aortic 
stenosis to the pressure load imposed by AS, it has an adverse consequence in the form of 
decreased left ventricular compliance. As a result a greater intracavitary pressure is 
required for LV filling. Some patients with AS have an increase in stiffness of left 
ventricle, simply because of increased muscle mass with no alteration in diastolic 
properties of each unit of myocardium (normal muscle stiffness);  where as others exhibit 
increases in both chamber and muscle stiffness. This increased stiffness constitutes to 
elevated left ventricular filling pressure. Diastolic dysfunction may revert towards normal 
after aortic valve replacement. However some people continue to have morbidity and 
mortality due to diastolic dysfunction even though they underwent aortic valve 
replacement.   
Changes in the transmitral pressure gradient are demonstrated accurately by mitral 
inflow Doppler velocities, which reflect the relation between LV and LA pressures 
during diastole. The three type of myocardial fiber are the longitudinal, radial, and 
circumferential fibers. Normal myocardial relaxation is a result of the well-coordinated 
motion of these fibers, which causes the twisting and untwisting of the heart.  
It is most practical for echocardiography to record the longitudinal motion of the 
myocardium with myocardial relaxation the LV cavity elongates and expands laterally. 
The longitudinal motion of the mitral annulus has been shown to reflect the rate of 
myocardial relaxation. The velocity of the mitral annulus can be recorded with tissue 
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Doppler imaging, which has become an essential part of the echocardiographic evaluation 
of diastolic function. 
            For each person, the proportion of LV filling during the early and late phase of 
diastole depends on elastic recoil, the rate of the myocardial relaxation, chamber 
compliance, and LA pressure. In cardiac disease, the status of these variables depends on 
the interaction of the disease process, the baseline diastolic properties, and LV volume. 
The LV filling pattern is the result of the transmitral pressure gradient produced by these 
various factors.  
Therefore, after the 2D echocardiographic study, LV diastolic filling is analyzed 
the transmitral pressure gradient. In most patients the LV diastolic filling pattern can be 
determined with 2D echocardiography and mitral inflow recording. However a definitive 
assessment of diastolic filling and estimation of filling pressure may require tissue 
Doppler pulmonary vein Doppler, hepatic vein Doppler and color M-mode imaging of 
mitral inflow, occasionally, with an alteration in the loading condition. 
Clinical presentation: 
Symptoms: 
 The cardinal symptoms in patients with aortic stenosis are exertional dyspnoea, 
angina, syncope and ultimately heart failure. The mechanism of exertional dyspnoea may 
be left ventricular diastolic dysfunction with elevation of LV end diastolic pressure 
leading to pulmonary congestion. Exertional symptoms may be due to limited ability to 
increase cardiac output with exercise. More severe exertional dyspnoea with orthopnoea 
and paroxysmal nocturnal dyspnoea are relatively very late symptoms. 
 Angina pectoris occurs in two thirds of patients with severe AS with half of whom 
have obstructive coronary artery disease. Angina in AS may be due to increased demand 
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due to increased LV mass, increased systolic workload, prolonged ejection time, reduced 
coronary flow reserve and coexisting coronary artery disease. Very rarely angina results 
from calcific emboli. 
 Syncope is most commonly due to reduced cerebral perfusion that occurs during 
exertion when arterial pressure decreases as a consequence to systemic vasodilatation and 
fixed cardiac output. Syncope is also attributed to malfunctioning baroreceptor response 
and transient ventricular fibrillation occurs during exertion in patients with AS.   
 Other late findings in AS includes atrial fibrillation, pulmonary hypertension and 
systemic hypertension. Gastrointestinal bleeding may occur due to acquired deficiency in 
Von Willebrand factor, which is correctable by aortic valve replacement. 
Diastolic dysfunction: 
 Diastolic dysfunction accounts for nearly 50% of patients with heart failure. 
These patients have heart failure even though their systolic function is normal. Abnormal 
myocardial relaxation and increased filling pressures have to be demonstrated to establish 
the diagnosis of diastolic heart failure29. Therefore, the following three conditions must 
be met to consider cardiac function to be entirely normal:  
1) Normal systolic function,  
2) Normal myocardial relaxation, and  
3) Normal diastolic filling pressure at rest and with exertion.  
Doppler echocardiography is the most practical method for assessing filling 
patterns and myocardial relaxation and for estimating LV filling pressures at rest and 
with exertion by recording flow velocities from the atrioventricular valves, central veins, 
and myocardial tissue. 
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Although patients with primary diastolic heart failure do not have an obvious 
abnormality of either systolic function or a major cardiac structure, a two-dimensional 
(2D) echocardiography study is rarely normal. The thickness of the LV wall is frequently 
increased and the left atrium (LA) is usually enlarged because of the chronic increase in 
LV filling pressure. The increase in LV wall thickness may be due hypertrophic 
cardiomyopathy infiltrative cardiomyopathy, or obesity.  
The normal cycle of cardiac contraction and relaxation requires a precise, 
transient increase and decrease in the intracellular concentration of calcium ions. The 
sarcoplasmic reticulum helps orchestrate the movement of calcium during each 
contraction end reach relaxation. The contraction of cardiac muscle is initiated by the 
cellular action potential that causes the opening of L-type sarcolemmal calcium channels 
through which calcium ions results in the release of more calcium ions from the adjacent 
sarcoplasmic reticulum through ryanodine receptor channels, a process called calcium-
induced calcium release. This calcium ions bind to Troponin C, which ultimately 
disinhibits the inter-action of actin and myosin and result in the formation of cross-
bridges.  
Myocardial relaxation is accomplished primarily by the removal of calcium ions 
from Troponin C by an enzyme in the sarcoplasmic reticulum-called saroplasmic 
reticulum adenosine triphosphastase (SERCA2), and the sarcolemmal sodium-calcium 
exchanger. In humans, approximately 75% of calcium ions are removed by SERCA2 and 
25% by the sodium-calcium exchanger30.  
The activity of SERCA2 is modulated by phospholamban, a protein located near 
SERCA2 sarcoplasmic reticulum. Through phosphorylation by protein kinase A and 
other kinases, phospholamban enhances calcium ion uptake by SERCA2.Failure of the 
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mechanisms of reuptake of calcium ions extruded during contraction can result in the 
slowing of the relaxation or the inability of the cytosolic calcium concentration to return 
to normal diastolic levels. The latter cause diastolic calcium overload and incomplete 
relaxation (includes excessive diastolic tension or stiffening).  
An experimental model of senescence has demonstrated that decreased uptake of 
calcium ions by the sarcoplasmic reticulum during relaxation is associated with a 
decrease in the concentration and activity of SERCA2 more recently; SERCA2 levels 
were found to be greatly decreased in senescent human myocardium31. This decrease was 
associated with impaired myocardial function at baseline, and further deterioration 
occurred during hypoxic conditions.  
Thus a decrease in SERCA2 concentration and associated decrease in uptake of 
calcium ions by the sarcoplasmic reticulum are thought to influence diastolic dysfunction. 
Despite normal systolic function, the vulnerability of calcium reuptake is a contributing 
factor to abnormal LV relaxation early in cardiac disease.  
Completely normal 2D echocardiographic findings (i.e, normal LVEF wall 
thickness LA size, and ventricular septal motion) usually exclude diastolic dysfunction, 
but a comprehensive Doppler examination is required to assess diastolic function. 
Measurement of LA volume is also helpful in assessing diastolic function. The cardiac 
atria are actively remodeled during the evolution of heart failure.  
Normal LA volume in a patient with advanced diastolic dysfunction is most 
unusual unless the LV filling pressure increases abruptly because of the sudden onset of a 
structural abnormality, such as severe mitral or aortic regurgitation due to sudden 
valvular disruption. LA volume is a good predictor of the development of atrial 
fibrillation and long-term outcome in various cardiac disorders. 
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Assessment of diastolic dysfunction: 
        Diastolic filling usually is classified on the basis of the peak mitral flow velocity of 
the early rapid filling wave (E), peak velocity of the late filling wave due to atrial 
contraction (A), and the E/A ratio. To measure E and A velocities reliably, the Doppler 
velocity recording should be satisfactory. Tachycardia or first-degree atrioventricular 
block may result in fusion of the E and A velocities. In fact, A velocity may be relatively 
increased if it starts before E velocity has reached zero. Generally, if E velocity is more 
than 20 cm/s at the beginning of A velocity (E at A), both the A velocity and E/A ratio 
may be affected by the fusion of the E and A velocities. 
The diastolic filling pattern is characterized further by measuring the deceleration 
time (DT), the interval from the peak of the E velocity to its extrapolation to baseline. In 
patients with a relaxation abnormality as the predominant diastolic dysfunction, DT is 
prolonged because, with a slower and continued decrease in LV pressure until  
mid to late diastole, it takes longer for LA and LV pressures to equilibrate. DT is 
shortened if there is rapid filling due to vigorous LV relaxation and elastic recoil, as in 
normal young subjects, or, conversely, if there is a decrease in LV compliance or marked 
increase in LA pressure.  
The isovolumic relaxation time (IVRT) is the interval from aortic valve closure to 
mitral valve opening. It generally parallels DT, being prolonged with abnormal relaxation 
and shortened with rapid relaxation or increasing filling pressure (or both). The duration 
of mitral flow with atrial contraction is useful for estimating LV end-diastolic pressure 
(LVEDP)32,33 , because it is shortened with a higher LVEDP.  
In a patient with impaired relaxation and mild-to-moderate increase in filling 
pressures, the mitral flow pattern resembles a normal filling pattern because of the 
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opposing effects of myocardial relaxation and increased filling pressures on mitral 
velocity variables. Therefore, the normalized filling pattern due to moderate diastolic 
dysfunction has been termed pseudonormalized mitral inflow. We need to demonstrate 
impaired relaxation or increased filling pressure to characterize a normal-appearing mitral 
inflow as a pseudonormalized pattern. 
The Valsalva manoeuvre, which is performed by forceful expiration (about 40 
mm Hg) against a closed nose and mouth, produces a complex hemodynamic process 
involving four phases. Frequently, during a physical examination, this manoeuvre is used 
to assess a cardiac murmur; it is also helpful in the echocardiographic assessment of 
diastolic function. Because LV preload is reduced during the strain phase (phase II) of the 
Valsalva manoeuvre, this manoeuvre decreases E velocity, lengthens DT of the E 
velocity, and increases A velocity if the patient has already increased filling pressure. In 
patients with normal filling pressure, the Valsalva manoeuvre decreases both the E and A 
velocities and lengthens DT. Therefore, the Valsalva manoeuvre is used to differentiate a 
normal mitral inflow velocity pattern from a pseudonormal pattern34. In patients with a 
restrictive filling pattern, the reversibility of advanced diastolic dysfunction is assessed 
with the Valsalva manoeuvre. However, not all patients can perform a Valsalva 
manoeuvre satisfactorily. 
Mitral Annulus Velocities: 
Although the movement of the mitral annulus can be recorded with M-mode 
echocardiography, tissue Doppler imaging is the method of choice for recording the 
longitudinal velocities of the mitral anulus35,36. These velocities are recorded from the 
apical four-chamber view by placing a 2 to 5-mm sample volume over the lateral or 
medial portion of the mitral annulus. Normally, three distinct velocities are recognized: 
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systolic (Sa), early diastolic (Ea), and late diastolic (Aa) velocities. Additional isovolumic 
or mid-diastolic velocities may be recorded. Ea velocity is essential for classifying the 
diastolic filling pattern and estimating filling pressures. It also is extremely helpful in 
distinguishing between constrictive pericarditis and other forms of myocardial diastolic 
heart failure. Aa velocity has been studied less well, but it has been found to correlate 
with LA function37.  
Ea velocity reflects relaxation of the myocardium. In normal subjects, Ea 
increases as the transmitral gradient increases with exertional or increased preload; 
however, in patients with impaired myocardial relaxation, Ea is reduced at baseline and 
does not increase as much as in normal subjects with increased preload38. Therefore, a 
decrease in Ea is one of the earliest markers for diastolic dysfunction, and this decrease is 
present in all stages of diastolic dysfunction39. Ea decreases with aging even earlier than 
the decrease in mitral inflow E velocity. Because Ea velocity remains reduced and mitral 
E velocity increases with higher filling pressure, the ratio between E and Ea, E/Ea, 
correlates well with LV filling pressure or pulmonary capillary wedge pressure. 
Normally, the Ea velocity from the lateral annulus is higher than the Ea velocity from the 
medial annulus (normal, 15 cm/s vs. 10 cm/s). 
Mitral Inflow Propagation Velocity (Vp): 
Normal LV relaxation induces an active suction of blood and creates diastolic 
intraventricular gradients. Courtois and colleagues41 demonstrated that pressures at the 
apex are lower than those at the base of heart, and this intraventricular gradient decreases 
or disappears with a decrease in myocardial relaxation. The intraventricular pressure 
gradient implies that there are regional differences in myocardial relaxation, with the 
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apex segment showing the earliest relaxation in a normal heart. Color M-mode of mitral 
inflow displays color-coded mean velocities from the annulus area to the apex over            
 time42-44. Color M-mode is obtained by placing a cursor line along the central part of the 
mitral inflow blood column. The colour flow baseline needs to be shifted to lower the 
Nyquist limit so the central highest velocity jet is blue.  
There are several ways to measure Vp from colour M-mode. The most practical 
way is to trace the slope of the first aliasing velocity (red to blue) from the mitral valve 
plane to 4 cm distal to the LV. The normal flow propagation velocity is 50 cm/s or 
higher. It correlates with myocardial relaxation. Although Vp initially was thought to be 
independent of preload, subsequent studies have suggested that it depends on preload and 
cardiac size45. Vp has been used to estimate pulmonary capillary wedge pressure (PCWP) 
as follows: 
• PCWP = 4.5 - [103/(2 × IVRT) + Vp] - 9 
• PCWP = (5.27 × E/Vp) + 4.6 
Pulmonary Vein Flow Velocities: 
A pulmonary vein Doppler recording has four distinct velocity components two 
systolic velocities (PVS1 and PVS2), diastolic velocity (PVd), and atrial flow reversal 
velocity (PVa). The first systolic forward flow, PVS1, occurs early in systole and is 
related to atrial relaxation, which decreases LA pressure and fosters pulmonary venous 
flow into the LA. The second systolic forward flow, PVS2, occurs in mid to late systole 
and is produced by the increase in pulmonary venous pressure. 
 At normal LA pressure, the late systolic increase in pulmonary venous pressure is 
larger and more rapid than LA pressure. However, at elevated filling pressures, the late 
systolic pressure increase in the LA is equal to or more rapid than that in the pulmonary 
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vein, resulting in earlier peak velocity of PVS2. The remaining pulmonary vein flow 
velocity components (PVd, PVa, PVS1) follow phasic changes in LA pressure47. With 
normal atrioventricular conduction, the systolic components are closely connected, and a 
distinct PVS1 peak velocity may not be identified in 70% of patients. During diastole, 
forward flow velocity (PVd) occurs after opening of the mitral valve and in conjunction 
with the decrease in LA pressure. With atrial contraction, the increase in LA pressure 
may result in flow reversal into the pulmonary vein. The extent and duration of the flow 
reversal are related to LV diastolic pressure, LA compliance, and heart rate. The diastolic 
phase of pulmonary venous flow resembles early mitral flow (E).  
The peak velocity and DT correlate well with those of mitral E velocity because 
the LA functions mainly as a passive conduit for flow during early diastole. The DT of 
pulmonary vein diastolic forward flow velocity (PVd) becomes shorter as PCWP 
increases48. Both peak velocity (PVa) and duration of pulmonary vein atrial flow reversal 
(PVa duration) are important measurements that increase with higher LVEDP. 
Myocardial Performance Index: 
 Left ventricular myocardial performance was calculated as follows. The mitral 
inflow is interrogated by pulse wave doppler in the apical 4 chamber view and the time 
interval from end of A wave to the onset of the following E wave is noted as a in 
milliseconds. Then the aortic valve is interrogated by pulse wave doppler in the apical 
five chamber view. The total aortic ejection time is noted as b. Five consecutive cardiac 
cycles were averaged to obtain each value for ‘a’ and ‘b’ to correct for heart rate variation 
and measurement errors. 
 The time interval ‘a’ denotes combination of isovolumetric contraction time 
(IVCT), ejection time (ET) and isovolumetric relaxation time (IVRT). As the doppler 
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period b is the aortic ET, the sum of IVCT and IVRT is derived by subtracting b from a. 
MPI is calculated as MPI = a-b/b and a valueless ratio is obtained. Normal value of MPI 
is 0.39 ± 0.05. 
Left Atrium: 
The LA, located as a conduit between the pulmonary vein and LV, reflects the 
burden of LV diastolic filling. Experiments have demonstrated a progressive increase in 
the dimension of the LA chamber with atrial remodelling in heart failure49. Mechanical 
stretch of the LA induces hypertrophy of LA myocytes and, subsequently, fibrosis, which 
predispose to the development of atrial fibrillation. It has been shown that the size and 
volume of LA increase as diastolic dysfunction progresses.  
Therefore, LA volume has been termed glycosylated haemoglobin of diastolic 
dysfunction. Whereas the mitral inflow velocity pattern reflects instantaneous changes in 
filling pressure, LA volume reflects the chronicity of diastolic dysfunction. Therefore, not 
unexpectedly, LA volume is predictive of future cardiovascular events such as atrial 
fibrillation, heart failure, stroke, and death. LA volume is helpful in assessing diastolic 
function: an entirely normal LA volume can exclude clinically important diastolic 
dysfunction50. A normal-appearing mitral inflow velocity pattern usually represents a 
pseudonormalized pattern if LA volume is increased. 
Grading of Diastolic Dysfunction (or Diastolic Filling Pattern): 
• Grade 1 = impaired relaxation pattern with normal filling pressure 
                       1a = impaired relaxation pattern with increased filling pressure 
• Grade 2 = pseudonormalized pattern 
• Grade 3 = reversible restrictive pattern 
• Grade 4 = irreversible restrictive pattern 
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Normal Diastolic Filling Pattern: 
The rates of myocardial relaxation and compliance change with aging, so that 
different diastolic filling patterns are expected for different age groups. In normal young 
subjects, LV elastic recoil is vigorous and myocardial relaxation is swift; therefore, most 
filling is completed during early diastole, with only a small contribution at atrial 
contraction. Therefore, E/A is usually 1.5 or higher, DT 160 to 230 milliseconds (septal), 
Ea 10 cm/s or more, E/Ea less than 8, and Vp 50 cm/s or more.  
With the Valsalva manoeuvre, both E and A velocities decrease with lengthening 
of DT, so that the E/A ratio remain the same. With normal myocardial relaxation, the 
longitudinal mitral annulus diastolic velocity pattern mirrors that of normal mitral inflow: 
early diastolic velocity (Ea) is higher than the late diastolic velocity (Aa). The lateral 
annulus velocity is always higher than septal Ea. Ea increases with an increasing 
transmitral gradient in healthy subjects, so that E/Ea is similar at rest and with exercise 
(usually <8). Mitral inflow propagation velocity is normally 50 cm/s or greater.  
With aging, the rate of myocardial relaxation and elastic recoil gradually 
decrease, resulting in slow LV pressure declines and slower filling. With normal LA 
pressure, the pressure crossover between the LV and LA (i.e., mitral valve opening) 
occurs later and the early transmitral pressure gradient is decreased. Hence, the IVRT 
becomes longer and the E velocity in normal subjects gradually decreases with increasing 
age. Decreased filling in early diastole retards the equilibration of pressure between the 
LV and LA, resulting in a longer DT. Because early LV filling is reduced, the 
contribution of atrial contraction to LV filling becomes more important. This results in a 
gradual increase in A velocity with aging. 
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 At the age of 65 years, E velocity approaches A velocity, and in persons older 
than 70 years, the E/A ratio is usually less than 1.0. Pulmonary vein flow velocities show 
similar changes with aging: diastolic forward flow velocity decreases as more of the LV 
fills at atrial contraction, and systolic forward flow velocity becomes more prominent. 
This is similar to the grade 1 filling pattern. 
Abnormal Patterns: 
Grade 1 Diastolic Dysfunction (Impaired Myocardial Relaxation): 
In nearly all types of cardiac disease, the initial abnormality of diastolic filling is 
slowed or impaired myocardial relaxation. Typical examples of cardiac lesions that 
produce impaired relaxation include LV hypertrophy, hypertrophic cardiomyopathy, and 
myocardial ischemia or infarction. The IVRT is prolonged. Mitral E velocity is decreased 
and A velocity is increased, producing an E/A ratio less than 1, with prolonged DT. 
Whenever the E/A ratio is less than 1, impaired relaxation is usually present. (The reverse 
is not true.) PVd parallels mitral E velocity and is also decreased, with compensatory 
increased flow in systole. The duration and velocity of PVa are usually normal, but they 
may be increased if the LVEDP is high. 
Ea is also reduced, usually less than 7 cm/s (at the septal annulus), and mitral flow 
propagation velocity is reduced, less than 50 cm/s. In most patients with the described 
mitral inflow velocity pattern, diastolic filling pressure is not increased and E/Ea is 8 or 
less (20). In a subgroup of patients, E/Ea is greater than 15, with E/A less than 1. This 
pattern has been designated as grade 1a diastolic dysfunction to emphasize that filling 
pressure is increased in the presence of a typical grade 1 mitral inflow velocity pattern. 
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Grade 2 Diastolic Dysfunction (Pseudonormalized Pattern): 
As diastolic function deteriorates, the mitral inflow pattern goes through a phase 
that resembles a normal diastolic filling pattern, that is, the E/A ratio is 1 to 1.5 and DT is 
normal at 160 to 220 milliseconds. This is the result of a moderately increased LA 
pressure superimposed on a relaxation abnormality. This is referred to as the 
pseudonormalized mitral flow filling pattern, and it represents a moderate stage of 
diastolic dysfunction. The pseudonormal pattern can be distinguished from a true normal 
pattern by the following: 
• The best way to identify a pseudonormalized pattern is to demonstrate impaired 
myocardial relaxation by Ea less than 7 cm/s and increased filling pressure by 
E/Ea greater than 15. Frequently, there is mid-diastolic flow due to marked 
impairment of myocardial relaxation. 
• In patients with an LV of abnormal size or systolic dysfunction or with increased 
wall thickness, impaired relaxation is expected as the baseline diastolic function 
without increased filling pressure, and a normal E/A ratio suggests that increased 
LA pressure is masking the abnormal relaxation. 
• A decrease in preload, by having the patient sit, perform the Valsalva manoeuvre, 
or take sublingual nitro-glycerine, may be able to unmask the underlying impaired 
relaxation of the LV, causing the E/A ratio to decrease by 0.5 or more and 
reversal of the E/A ratio24. In normal subjects, both the E and A velocities 
decrease more proportionally with a decrease in filling. 
• A pseudonormal pattern is demonstrated by showing a shortening of mitral A 
duration in the absence of a short PR interval or by demonstrating prolonged PVa 
exceeding mitral A duration. 
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• Colour M-mode of mitral inflow can determine the rate of flow propagation in the 
LV45. With worsening diastolic function, myocardial relaxation is always 
impaired and flow propagation is slow, even when LA pressure and mitral E 
velocity are increased. This is less reliable in patients who have a normal LV 
cavity size. 
Grade 3 and 4 Diastolic Dysfunction (Restrictive Filling): 
The term restrictive diastolic filling, or restrictive physiology, should be 
distinguished from restrictive cardiomyopathy. Restrictive physiology can be present in 
any cardiac abnormality or in a combination of abnormalities that produce decreased LV 
compliance and markedly increased LA pressure. The increase in LA pressure results in 
earlier opening of the mitral valve, shortened IVRT, and an increased initial transmitral 
gradient (high E velocity). 
 Early diastolic filling in a noncompliant LV causes a rapid increase in early LV 
diastolic pressure, with rapid equalization of LV and LA pressures producing a shortened 
DT. Atrial contraction increases LA pressure, but A velocity and duration are shortened 
because LV pressure increases even more rapidly. When LV diastolic pressure is 
markedly increased, there may be diastolic mitral regurgitation during mid-diastole or 
with atrial relaxation. Therefore, restrictive physiology is characterized by mitral flow 
velocities that show increased E velocity, decreased A velocity (<<E), and shortened DT 
(<160 milliseconds) and IVRT (<70 milliseconds). Typically, the E/A ratio is more than 
2.0 and occasionally increases to 5 (e.g., E velocity of 1.5 m/s and A velocity of 0.3 m/s). 
 It should be emphasized, however, that myocardial relaxation continues to be 
impaired in patients with restrictive filling (except for those with a sudden disruption of 
cardiac structure), but it is masked by decreased LV compliance with markedly increased 
 33
LA pressure. Systolic forward flow velocity in the pulmonary vein is decreased because 
of increased LA pressure and decreased LA compliance. Pulmonary vein forward flow 
stops at mid to late diastole, reflecting the rapid increase in LV pressure; at atrial 
contraction, the increase in LA pressure can produce a prolonged PVa; however, PVa 
may not be seen if atrial contraction occurs when the pulmonary vein flow velocity is 
relatively high because of tachycardia. 
Because myocardial relaxation is impaired in patients with a restrictive filling 
pattern, mitral annulus Ea is reduced (<7 cm/s) and flow propagation velocity is usually 
reduced. E/Ea is usually more than 15. Flow propagation velocity may not be reduced in 
restrictive filling when the LV cavity is small and systolic function is well preserved. The 
Valsalva manoeuvre may reverse a restrictive filling pattern to a grade 1 or 2 pattern, 
indicating the reversibility of high filling pressure (grade 3 diastolic filling). However, 
even if the restrictive filling pattern does not change with the Valsalva manoeuvre, 
reversibility cannot be excluded because the Valsalva manoeuvre may not be adequate or 
filling pressure may be too high to be altered by the manoeuvre. Diastolic filling should 
be graded as irreversible restrictive (grade 4) only when there is objective evidence of a 
persistent restrictive pattern with normal filling pressure. 
Techniques for Diastolic Doppler Parameters: 
Transducer position: The ultrasound beam needs to be parallel with the direction 
of blood flow to obtain the optimal flow signal. Because of the location of the papillary 
muscles, normal mitral inflow is directed toward the mid-to-distal portion of the 
posterolateral wall of the LV, which is approximately 20 degrees lateral to the apex. An 
optimal transducer position for recording flow velocities in the pulmonary veins varies 
depending on which view and which vein is to be interrogated. Usually, an apical four-
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chamber view is used to record flow velocities from the right upper pulmonary vein. 
Color-flow imaging may be helpful in guiding the ultrasound beam so it is parallel with 
mitral inflow or pulmonary venous flow 
Sample volume size and location: To record peak mitral inflow velocities, the 
pulsed wave Doppler technique is used, with a sample volume of 1 to 2 mm placed 
between the tips of the mitral leaflets during diastole. The sample volume may be moved 
toward the mitral annulus to better record the duration of the A velocity. 
To measure IVRT (i.e., the interval from aortic valve closure to mitral valve 
opening), a 3 to 4-mm sample volume is placed in the area of the mitral leaflet tips. Next, 
the transducer beam is angulated toward the LV outflow tract until aortic valve closure 
appears above and below the baseline. An alternative technique is to use continuous wave 
Doppler echocardiography to record aortic and mitral flow simultaneously.  
Hepatic vein Doppler velocities are recorded with subcostal imaging, using a 2 to 
5-mm pulsed wave sample volume placed 1 to 2 cm proximal to the junction with the 
inferior vena cava. Flow velocity in the SVC is obtained with a 2 to 5-mm pulsed wave 
sample volume at a depth of 5 to 7 cm from the right supraclavicular area. 
Mitral annulus velocity is recorded by tissue Doppler imaging. Sample volume 
size can vary from 2 to 5 mm over the lateral or septal mitral annulus. For the color M-
mode of mitral flow, a cursor is placed along the center of mitral inflow on color flow 
imaging. The color flow sector should be adjusted so it is slightly wider than the width of 
mitral inflow and it should be extended all the way to the apex. 
Velocity scale and filter: These should be adjusted according to the peak 
velocities of Doppler recording. Compared with mitral and tricuspid flow velocities 
(range, 0.5-1.5 m/s), venous flow velocities are lower (range, 0.1-0.5 m/s), and because 
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of this, velocity scales should be expanded and the velocity filter should be low. For 
tissue Doppler velocity recording, the Doppler gain and velocity filter need to be 
lowered. 
Invasive measurement of left ventricular stiffness: 
Stiffness or elastance is defined as the relationship between the change in stress 
and the resulting strain. On the chamber level, the elastance of the LV varies over the 
cardiac cycle (time-varying elastance), and end-systolic and end-diastolic elastance are 
defined by the changes in systolic or diastolic pressure associated with a change in end-
systolic or end-diastolic volume (40). Increases in LV diastolic stiffness will mandate 
higher LA pressures to maintain filling and thus promote elevated pulmonary venous 
pressures and pulmonary congestion when LA pressures are elevated or reduced cardiac 
output when LA pressures are not elevated. 
The time constant of relaxation (tau, t) describes the rate of LV pressure decay 
during isovolumic relaxation. Measurement of tau requires high-fidelity manometer 
tipped LV catheters for precise determination. The pressure (P) and time (t) data during 
the period from end-systole (peak - dP/dt) to the onset of LV filling (determined from LA 
to LV crossover pressure, or estimated as 5 mm Hg above the end-diastolic pressure) is 
used to calculate tau. The pressure-time data during isovolumic relaxation are fit to 
various equations to derive the value of tau. The equations used make different 
assumptions regarding the LV minimum pressure obtained.  
The Weiss equation is LV P = Poe-t/   ( -tau) 
Where P0 = LV P at end ejection, assumes a zero asymptote (or that the LV 
minimum pressure must be positive) and thus derives tau as the negative inverse of the 
slope of the relationship between the natural log (ln) of LV pressure and time during 
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isovolumic relaxation). The “logistic” equation lets the data drive the asymptote and 
allows for negative LV minimum pressures, as has been documented in animal studies. 
With all methods, the larger the value of tau, the longer it takes for the LV to relax and 
the more impaired is relaxation. A normal value for tau is less than 40 milliseconds in 
most age groups and relaxation is complete by 3.5 × tau (less than 140 milliseconds). 
Treatment of aortic stenosis: 
 The most important principle in management of adults with AS is patient 
education regarding the disease course and typical symptoms. Patients should be advised 
to report promptly the development of any symptoms possibly related to AS. Patients 
with severe AS should be cautioned to avoid vigorous athletic and physical activity. 
However, such restrictions do not apply to patients with mild obstruction. Evolving 
recommendations for infective endocarditis prophylaxis should be explained. Although 
medical therapy has not been shown to affect disease progression, adults with AS (as any 
other adult) should be evaluated and treated for conventional coronary disease risk 
factors, as per established guidelines. 
Echocardiography is recommended for initial diagnosis and assessment of AS 
severity, for assessment of LV hypertrophy and systolic function, for reevaluation in 
patients with changing signs or symptoms, and for re-evaluation annually for severe AS, 
every 1-2 years for moderate AS, and every 3 to 5 years for mild AS. Because patients 
may tailor their lifestyles to minimize symptoms or may ascribe fatigue and dyspnoea to 
deconditioning or aging, they may not recognize early symptoms as important warning 
signals, although these symptoms often can be elicited by a careful history. Exercise 
testing may be helpful in apparently asymptomatic patients to detect covert symptoms, 
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limited exercise capacity, or an abnormal blood pressure response. Exercise stress testing 
should be absolutely avoided in symptomatic patients.  
Symptomatic patients with severe AS are usually operative candidates because 
medical therapy has little to offer. However, medical therapy may be necessary in 
patients who are considered to be inoperable (usually because of comorbid conditions 
that preclude surgery). Although diuretics are beneficial when there is abnormal 
accumulation of fluid, they must be used with caution because hypovolemia may reduce 
the elevated LV end-diastolic pressure, lower cardiac output, and produce orthostatic 
hypotension. ACE inhibitors should be used with caution but are beneficial in treating 
patients with symptomatic LV systolic dysfunction who are not candidates for surgery. 
They should be initiated at low doses and increased slowly to target doses, avoiding 
hypotension. Beta-adrenergic blockers can depress myocardial function and induce LV 
failure and should be avoided in patients with AS. 
Atrial flutter or fibrillation occurs in less than 10 percent of patients with severe 
AS, perhaps because of the late occurrence of left atrial enlargement in this condition. 
When such an arrhythmia is observed in a patient with AS, the possibility of associated 
mitral valvular disease should be considered. When AF occurs, the rapid ventricular rate 
may cause angina pectoris. The loss of the atrial contribution to ventricular filling and a 
sudden fall in cardiac output may cause serious hypotension. Therefore AF should be 
treated promptly, usually with cardioversion. New onset AF in a previously 
asymptomatic patient with severe AS may be a marker of impending symptom onset. 
Management of concurrent cardiac conditions, such as hypertension and coronary 
disease, is complicated in patients with asymptomatic AS by the concern that 
vasodilatory effects of medications may not be offset by a compensatory increase in 
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cardiac output. Despite this concern, AS patients should receive appropriate treatment for 
concurrent disease, although medications should be started at low doses and slowly 
titrated upward with close monitoring of blood pressure and symptoms. Adults with 
asymptomatic severe AS can undergo noncardiac surgery and pregnancy with careful 
hemodynamic monitoring and optimization of loading conditions. However, when 
stenosis is very severe, elective AVR prior to noncardiac surgery or a planned pregnancy 
may be considered. 
Aortic valve replacement: 
AVR is recommended in adults with symptomatic severe AS, even if symptoms 
are mild. AVR also is recommended for severe AS with an ejection fraction less than 50 
percent and in patients with severe asymptomatic AS who are undergoing coronary 
bypass grafting or other heart surgery. In addition, AVR may be considered for severe AS 
when exercise testing provokes symptoms or a fall in blood pressure. In asymptomatic 
patients with severe AS and a low operative risk, AVR may be considered when markers 
of rapid disease progression are present or when AS is very severe, depending on patient 
preferences regarding the risk of earlier intervention versus careful monitoring with 
intervention promptly at symptom onset. Coronary angiography should be performed 
before valve replacement in most adults with AS Surgical AVR is the procedure of 
choice for relief of outflow obstruction in adults with valvular AS.  
If surgical repair is not feasible as attempts at debridement of valve calcification 
have not been successful. Balloon aortic valvotomy has only a modest hemodynamic 
effect in patients with calcific AS and does not favourably impact long-term outcome. 
Thus balloon aortic valvotomy is not recommended as an alternate to AVR for calcific 
AS. In selected cases, balloon valvotomy might be reasonable as a bridge to surgery in 
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unstable patients or as a palliative procedure when surgery is very high risk. Newer 
percutaneous methods for implantation of prosthetic valves in seriously ill patients who 
are not candidates for surgery are under development. Limited clinical experience has 
been reported to date Symptoms of pulmonary congestion (exertional dyspnoea) and of 
myocardial ischemia (angina pectoris) are relieved in almost all patients, and most 
patients will have an improvement in exercise tolerance, even if only mildly reduced 
prior to surgery. 
Hemodynamic results of AVR are also impressive; elevated end diastolic and 
end-systolic volumes show significant reduction. Impaired ventricular performance 
returns to normal more frequently in patients with AS than in those with AR or MR. 
However, the finding that the strongest predictor of postoperative LV dysfunction is 
preoperative dysfunction suggests that patients should, if possible, be operated on before 
LV function becomes seriously impaired. The increased LV mass is reduced toward (but 
not to) normal within 18 months after AVR in patients with AS, with further reduction 
over the next several years. Coronary flow reserve and diastolic function also 
demonstrate considerable improvement after AVR. However, interstitial fibrosis 
regresses more slowly than myocyte hypertrophy so that diastolic dysfunction may 
persist for years after successful valve replacement. 
 In patients with moderately or severely calcified valves in whom serial 
echocardiographic testing reveals a marked increase in aortic-jet velocity, the outcome is 
significantly worse, and an 80 percent event rate at two years can be expected. 
Because patients do not always report symptoms promptly, and in consideration of the 
elevated risk of death while patients await surgery, as well as the higher operative risk in 
symptomatic patients and those undergoing urgent surgery, it may be worthwhile 
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to consider early elective valve replacement instead of waiting for symptoms to develop 
in this high-risk group. 
 In the study by Pellikka et al52, only aortic-jet velocity and ejection fraction were 
independent predictors of the risk of subsequent cardiac events, whereas age, sex, and the 
presence or absence of hypertension, diabetes mellitus, left ventricular hypertrophy, 
electrocardiographic strain pattern, ventricular ectopic activity, and coronary artery 
disease, smoking status, and the use or nonuse of digoxin or diuretic drugs were not. In 
the study by Otto et al,26 the only predictors of outcome were aortic-jet velocity, the rate 
of change in this velocity, and functional status, but not age, sex, cause of aortic 
stenosis, left ventricular mass, or ejection fraction. Neither of these studies allowed any 
conclusions to be drawn about how to select high-risk patients who might benefit from 
early elective surgery. 
 In patients with moderately or severely calcified valves in whom serial 
echocardiographic testing reveals a marked increase in aortic-jet velocity, the outcome is 
significantly worse, and an 80 percent event rate at two years can be expected. 
Because patients do not always report symptoms promptly, and in consideration of the 
elevated risk of death while patients await surgery, as well as the higher operative risk in 
symptomatic patients and those undergoing urgent surgery, it may be worthwhile 
to consider early elective valve replacement instead of waiting for symptoms to develop 
in this high-risk group. 
  
.                                  
 
 
 41
                                            MATERIAL AND METHODS 
 
This study was performed in the Department of Cardiology, Government General 
Hospital, Chennai, during the year 2007 – 2010. The study is a prospective observational 
study involving 40 patients. 
Study group selection: 
Ethical committee clearance was obtained to conduct the study in our hospital.  
All subjects provided written informed consent to participate in the study before 
inclusion. 
Inclusion criteria:  
1. Moderate to severe aortic stenosis with normal LV systolic function 
Severe AS – peak velocity more than 4 m/sec or mean gradient more than 40 mmHg 
Moderate AS – peak velocity between 3 and 4 m/sec or mean gradient of 25 to 40 mmHg 
2. Age 30 – 75 years 
3. Both sexes 
4. Sinus rhythm 
Exclusion criteria: 
1. more than mild aortic insufficiency 
2. other valvular lesions ( except mild MR) 
3. LV systolic dysfunction (LVEF55%) 
4. systemic hypertension 
5. diabetes mellitus  
6. cardiomyopathies 
7. chronic obstructive airway disease  
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8. symptomatic respiratory disease ( bronchial asthma, pulmonary tuberculosis, 
bronchiectasis, etc) 
9. chronic kidney disease 
10. hypothyroidism 
11. cardiac surgeries in the past 
12. patients not in sinus rhythm 
 
Patient Characteristics: 
68 patients with valvular AS were screened for study. 8 of them were eliminated 
because of coexisting more than mild aortic regurgitation and another 10 patients were 
eliminated because of mild to moderate LV systolic dysfunction. Among the remaining 
50 patients one had associated mild mitral stenosis and two of them had more than mild 
mitral regurgitation. Another 7 patients were excluded due to presence of respiratory 
disease in the form of abnormal pulmonary function tests and diabetes mellitus. 
40 patients (male-28 / female-12) who met the inclusion criteria had isolated 
aortic valve disease in the form of degenerative calcific aortic stenosis (No.23), bicuspid 
aortic stenosis (No.13) and rheumatic etiology (No.4). Three patients had associated mild 
mitral regurgitation.  
Among the 40 patients included in the final phase of the study, 30 of them had 
severe AS and 10 of them had moderate AS. 28 patients (male-18 / female-10) were 
symptomatic and 12 (male-10 / female-2) were asymptomatic. Mean age of patients in 
this study was 49 ± 3.8 years  
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Male population consists of 64% (n=18) of symptomatic group and 83% (n=10) 
of asymptomatic group. Among female gender (total-12), 10 patients were symptomatic 
and 2 were asymptomatic. 
Out of 30 patients with severe AS, 26 patients (87%) were symptomatic and 4 
patients were asymptomatic. Among 10 subjects with moderate AS only 20% were 
symptomatic.   
 All the patients entered the study had detailed questionnaire. History was 
meticulously elicited with leading questions to bring out even subtle symptoms. Study 
population was subjected to routine blood investigations, chest X ray, ECG and detailed 
clinical examination. Informed written consent obtained from subjects after explaining 
the process of the study. 
 To test the functional capacity objectively, we had decided to subject the patients 
to six minute walk test. Because it is easily performed by even severely symptomatic 
individuals and has excellent reproducibility 
Six minute walk test ( 6MWT ): 
 The 6MWT was performed indoors, along a long, flat, straight, enclosed corridor 
with a hard surface that is seldom traveled. If the weather is comfortable, the test was 
performed outdoors. The walking course must be 30 m in length. A 100-ft hallway is 
required. The length of the corridor should be marked every 3 m. The turnaround points 
were marked with a cone (such as an orange traffic cone). A starting line, which marks 
the beginning and end of each 60-m lap, should be marked on the floor using brightly 
colored tape. 
Patient preparation includes,  
1. Comfortable clothing 
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2. Appropriate shoes for walking   
3. Patients used their usual walking aids during the test (cane, walker, etc.).  
4. The patient's usual medical regimen was continued.  
5. A light meal before early morning or early afternoon tests.  
6. Patients should not have exercised vigorously within 2 hours of beginning the test.  
Advantages of six minute walk test includes,  
1. Easy to perform  
2. Can be done in patient with marked limitation of physical activity 
3. Excellent reproducibility 
4. Correlates with symptoms 
5. Can be repeated on the same day on different times 
6. No instruments / hardware needed 
Six minute walk test was selected as a tool to measure the functional capacity 
since most of the population was around 60 years and being symptomatic. Six minutes 
walk test was performed according to American thoracic society protocol.               
30 meters even, hard walk surface was selected, measured and marked. Chairs 
were kept on the sides for patients to take rest in between the test. They were educated 
about the test and were encouraged to walk at possible maximum speed. Stop clock was 
being used. One individual was allowed to walk at a time. 6 minute walk distance was 
measured meticulously. Their baseline and post exercise blood pressure were recorded.  
They were informed to convey their symptom during exercise. Symptoms were identified 
and correlated during the six minute walk test.  
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Patients were requested to undergo echocardiographic examination with prior 
proper information. Mean pressure gradient and peak velocity across the aortic valve is 
used to define the severity of aortic stenosis and defined as follows,  
                   Severe AS - mean gradient > 40 mm Hg, V max > 4 m/sec.  
                   Moderate AS - mean gradient 25 - 40 mmHg, V max 3 - 4 m/sec. 
2D and M-Mode echocardiogram was performed many times in all possible views 
to obtain the diastolic parameters apart from routine echocardiographic examination. 
Among 2D parameters left atrial size, LV systolic and diastolic dimensions, early and late 
mitral filling velocities (E & A) were obtained. E deceleration time (DT), A duration and 
E-A duration was also measured.  Pulmonary vein systolic (S) and diastolic (D) flows 
and flow reversal were measured.  
Then tissue Doppler study was performed in apical 4 chamber view using pulse 
doppler sample to obtain septal mitral annulus velocities namely Ea and Aa. Indices like 
isovolumic relaxation time (IVRT), isovolumic contraction time (IVCT) and ejection 
time (ET) to calculate myocardial performance index (MPI) also obtained. LV end 
diastolic volume and LV end systolic volume were obtained using modified Simpson’s 
method and ejection fraction was calculated. 
To record peak mitral inflow velocities, the pulsed wave Doppler technique is 
used, with a sample volume of 1 to 2 mm placed between the tips of the mitral leaflets 
during diastole. The sample volume may be moved toward the mitral annulus to better 
record the duration of the A velocity. 
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         Measurement of aortic stenosis severity using CW doppler 
 
 
 
 
 
 
 
 
 
Figure 3; Continuous wave doppler across the aortic valve showing peak velocity 
of 4.59 m/s and mean gradient of 54 mmHg, suggestive of severe AS.  
 
                                     Early and late transmitral filling velocities 
 
 
  
 
 
 
 
 
Figure 4; Transmitral doppler showing E value of 91.4 cm/s, A value of 67.1 
cm/s and DT of 173 msec, suggestive of normal filling pattern.  
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                  Tissue Doppler – measuring velocities of septal mitral annulus    
 
 
 
 
 
 
 
 
 
Figure 5; Tissue doppler across medial mitral annulus showing reduced Ea value of 
3.9cm/s and E/Ea value of this patient was 23.4, which is markedly abnormal.   
 
Pulmonary vein Doppler – systolic, diastolic forward flow and diastolic reversal velocities  
 
 
 
 
 
 
 
 
Figure 6; pulse wave doppler across pulmonary vein showing S-74.5cm/s and   
D-44.6cm/s with S/D ratio of more than 1, which is normal. 
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Velocity scale and filter adjusted according to the peak velocities of Doppler 
recording. Compared with mitral and tricuspid flow velocities (range, 0.5-1.5 m/s), 
venous flow velocities are lower (range, 0.1-0.5 m/s), and because of this, velocity scales 
expanded and the velocity filter was kept low. For tissue Doppler velocity recording, the 
Doppler gain and velocity filter was adjusted to lower aliasing velocity. 
Tissue Doppler study was done in apical 4 chamber view with pulse wave doppler 
using 1-2 mm sample volume. Early and late mitral annulus velocities (Ea, Aa) were 
measured. Velocity scale adjusted to lower aliasing velocity. 
Echocardiography was performed using Phillips IE 33 machine by experienced 
consultants and average of three readings was taken as final. Velocities and durations 
were meticulously calculated to avoid observer bias. 
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                              PROFORMA 
 
  
Serial no:                                Initials:                                 Contact no: 
Age :                                       sex:            Address: 
CD no: 
Diagnosis : 
 
SHT:             DM:             CKD: 
COPD:            CAD:             HCM: 
Hypothyroidism: 
 
Symptoms : 
1.Dyspnoea; 
2.Angina; 
3.Syncope; 
4.others; 
 
Six minute walk distance: 
              Symptoms: 
 
Blood pressure:                                   Pulse: 
CVS:                                                   RS: 
Investigations: 
Bld.sugar; 
Sr.creatinine: 
Hb%; 
CBC; 
CXR-PA view; 
ECG; 
Pulmonary function test;  
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Exclusion criteria: 
CAD;      COPD; 
 
CKD;     ASTHMA; 
 
SHT;     HYPOTHYROIDISM; 
 
DM;                HCM; 
 
OTHER VALVULAR DISEASE; 
  
 
ECHO parameters: 2 D, M Mode and Doppler study: 
 
LVIDD;                 LVISD; 
EF; 
LA size: 
 
E velocity:                                  E - DT: 
A velocity:                 A- duration:                             E-A; 
E/A: 
 
PV-S:                                         D:                                            S/D: 
PVa velocity:                             PVa duration: 
TR peak velocity: 
 
Tissue Doppler Indices: 
Septal mitral annular velocities: 
Ea:                                      Aa: 
E/Ea: 
 
IVRT;                                IVCT;                                MPI; 
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                                                                RESULTS           
 
Statistics of echocardiographic parameters had been done with student’s t test (p 
values). Comparison of symptomatic and asymptomatic patients was done with chi 
square test. Gender comparison was done with chi square test. Mean age of the study 
population was 52±9 years, the lowest being 32 and the highest was 71 years. 
 
 
        Table 1; General and clinical characteristic of patients based on symptoms 
 
 
In the study group 28 patients were males and 12 were females. 10 patients had 
moderate AS and 30 patients had severe AS. 28 patients were symptomatic and 12 
Variables Asymptomatic (n=12) Symptomatic (n=28)     p Value
Age, years 47.9 ± 9.2  53.7 ± 8.8 0.082
Male, n % 10 (83.3%) 18(64.3%) 0.207
Sev AS  4 (33.3%)  26 (92.9%) < 0.001
E 85.2 ± 9.5 85.8 ± 10.3 0.881
A 81.9 ± 24.1 78.6 ± 26.6 0.699
E/A 1.1 ± 0.3 1.1 ± 0.4 0.784
Ea 8.9 ± 2.9 4.4 ± 0.8 < 0.001
Aa 8.3 ± 1.3 7.9 ± 1.7 0.466
E/Ea 10.6 ± 3.8 20.2 ± 3.5 < 0.001
PV S/D 1.4 ± 0.3 1.3 ± 0.4 0.362
MPI 0.6 ± 0.2 0.8 ± 0.1 0.008
EF 65.8 ± 5.4  61.2 ± 5.0 0.021
6 MWD 389.4 ± 63.8 214.8 ± 36.8 < 0.001 
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patients had no symptoms. 26(92%) patients with severe AS and 2(20%) patients with 
moderate AS had symptoms. Mean E/A ratio in symptomatic group was 1.1 ± 0.3 vs 
asymptomatic group was 1.1 ± 0.4(p-0.7), which did not show any significance. Mean Ea 
value was reduced in symptomatic group than in asymptomatic group. Mean Ea value in 
asymptomatic group was 8.9 ± 2.9 vs symptomatic group 4.4 ± 0.8 (p<0.001). 
 
 
 
 
 
 
 
 
Figure 7; Mean E/Ea was elevated (nearly doubled) in symptomatic patients 
when compared to asymptomatic group. 
 
 
E/Ea ratio is very much reduced in symptomatic patient s than in asymptomatic 
group. Mean E/Ea ratio in symptomatic group was 20.2 ±3.5 vs asymptomatic group 10.6 
± 3.8 (p<0.001). Other parameters like E, A, Aa, PV S/D and MPI did not statistically 
differ between symptomatic and asymptomatic patients. 
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In symptomatic patients the mean six minute walk distance was very much 
reduced when compared to asymptomatic group. (symptomatic group - 389.4 ± 63.8 
meters vs asymptomatic group - 214.8 ± 36.8 meters with P value of less than 0.05). In 
this study functional capacity was objectively tested using six minute walk testing, which 
revealed whether the symptomatic patients had reduced walk distance or not.  
               
            
    Table 2; Clinical and echocardiographic variables according to severity of AS 
 
 
Variables            AORTIC STENOSIS p – Value 
Moderate (n=10) Severe (n=30)
Age, years 49.7 ± 7.8 52.7 ± 9.6 0.334 
Male, n (%) 7 (70%) 21 (70%) NS  
Symptom, n(%) 2 (20%) 26 (86.7%) < 0.001 
E 88.9 ± 9.2 84.5 ± 10.1 0.212 
A 74.4 ± 20.2 81.3 ± 27.2 0.400 
E/A 1.3 ± 0.3 1.1 ± 0.4 0.187 
Ea 9.3 ± 3.1 4.5 ± 0.9 0.001 
Aa 8.1 ± 1.8 8.0 ± 1.5 0.871 
E/Ea 11.3 ± 6.6 19.4 ± 3.7 0.003 
PV S/D 1.5 ± 0.3 1.2 ± 0.4 0.041 
MPI 0.6 ± 0.2 0.7 ± 0.1 0.163 
EF 64.4 ± 7.2 62.0 ± 4.8 0.345 
6MWD(mt) 378.7 ± 92.8 230.0 ± 57.0 0.001 
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Most of the patients with severe AS had symptoms (86.7%) and reduced 6 minute 
walk distance (230 ± 57 meters). Only 20% of the patients with moderate AS had 
symptoms. Mean 6 minute walk distance in moderate AS group was 378± 92.8 meters. 
Ea values in severe AS group was lower than that of moderate AS group. Mean Ea value 
in moderate AS group was 9.3 ± 3 vs severe AS group was 4.5 ± 0.9 (p-0.001). Mean 
E/Ea ratio in the moderate AS was 11.3 ± 6.6 vs severe AS 19.4 ±3.7 (p-0.003). Other 
         Table 3; Cross table comparing severity of aortic stenosis and presence of symptoms 
 
Count AS 
Total Moderate Severe 
                    Symptom             No 8 4 12 
           Yes 2               26 28 
                                            Total 10 30 40 
                          Table 4; Table shows various formulas used for statistical power    
                                                               
 
Value Df 
symp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 15.873a 1 .000   
Continuity Correctionb 12.857 1 .000   
Likelihood Ratio 15.301 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear 
Association 
15.476 1 .000   
N of Valid Cases 40     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.00. 
b. Computed only for a 2x2 table 
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parameters like E, A, E/A, PV S/D, MPI and Aa did not significantly differ moderate and 
severe AS groups. 
The mean LV ejection fraction in asymptomatic group was 65.8% vs symptomatic 
group 61.2% which reveals LV ejection fraction in both the groups are normal and has no 
role in determining the symptoms.            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7; scatter plot shows linear inverse correlation between mean E/Ea value 
and six minute distance with R sq linear value of more than 0.7 suggests statistical 
significance. 
  
Six minute walk distance was 214.8 ± 36.8 meters in symptomatic group and 389 
± 63.8 meters in asymptomatic group ( r value -0.087 & p < 0.001 ) which is statistically 
very significant. Six minute walk distance did not differ between both sexes and it was 
altered only by the E/Ea value and Ea, not by difference in age. 
Scatter plot – Six minute walk distance Vs E / Ea
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.   
 
 
 
                
 
 
 
 
 
Figure 8; scatter plot shows linear direct correlation between Ea and six minute 
walk distance with R sq linear value of more than 0.7 which is statistically significant. 
 
  Table 5; Correlation between six minute walk test and echo or clinical variables 
Variables r – value p-Value 
Ea 0.869 < 0.001 
E / Ea -0.840 < 0.001 
MPI -0.459 0.003
EF 0.405 0.009
Symptom -0.871 < 0.001 
Age, years -0.236 NS
Sex -0.053 NS
Dx -0.701 < 0.001 
                                 
Scatter plot – Six minute walk distance Vs Ea
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Figure 9; shows percent of patients with symptoms in moderate AS and severe AS group 
 
 
 
                 
 
                                
 
 
 
 
 
Figure 10; Bar chart showing upto third quartile of patients with reduced 6MWD 
had elevated E/Ea value 
Quartiles of Six minute walk distance Vs Mean E / Ea
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After the analysis, it is found that most of the patients with symptoms have 
reduced six minutes walk distance. Diastolic parameters like transmitral filling velocities 
E, A, E/A ratio, pulmonary vein S/D and myocardial performance index (MPI) did not 
consistently associated with symptoms or six minute walk distance. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11; Scatter plot showing correlation between 6MWD and MPI. R sq linear 
value did not show any statistical significance between variables. 
 
   
This study demonstrates LV diastolic filling pressure, as represented by increased 
E/Ea correlates well with the symptoms and inversely associated with six minute walk 
Scatter plot – Six minute walk distance Vs 
Myocardial Performance Index
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distance. Among all the diastolic indices Ea and E/Ea were found to be statistically 
significant and consistently inversely associated with six minute walk distance.      
 
E/Ea value of less than eight is normal which correlate to normal pulmonary 
capillary wedge pressure (PCWP). When E/Ea is elevated more than fifteen (using lateral 
mitral annulus > 10) reflects PCWP of more than 20 mmHg. In this study Ea values 
obtained from medial septal annulus which is usually less than that obtained from lateral 
annulus.   
 In this study symptomatic individuals had higher E/Ea values and reduced six 
minute walk distance. They also had reduced Ea values. The other diastolic indices like 
E/A, deceleration time, isovolumic relaxation time, pulmonary vein S/D, and myocardial 
performance index were not statistically altered between symptomatic and asymptomatic 
patients. 
            Most patients with symptoms have severe aortic stenosis and reduced Ea and 
elevated E/Ea ratio. In patients with moderate aortic stenosis who were symptomatic had 
significantly increased E/Ea ratio. Among four patients with asymptomatic severe aortic 
stenosis with elevated E/Ea ratio had reduced six minute walk distance. This unmasks the 
patients' natural tendency to reduce the exertion and become functionally asymptomatic. 
They constitute the subgroup of patients who may develop significant diastolic 
dysfunction before the onset of symptoms. They should be identified and subjected for 
aortic valve replacement. 
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                                                               DISCUSSION 
 
 
In most patients with aortic stenosis, long-term survival after aortic valve 
replacement is excellent. In the absence of coronary artery disease, operative mortality is 
less than 2-3% and 10-years survival is more than 85%. Early and late mortality is 
dependent on various factors such as age, clinical symptoms, severity of valve disease, 
left ventricular function, presence of coronary artery disease etc 
Lund et al 51 observed an adverse early and late outcome in patients with diastolic 
dysfunction either alone or in combination with systolic dysfunction. 
Left ventricular diastolic dysfunction has been found in 50 to 60% of all patients 
with aortic stenosis and has been considered a major cause for the development of 
congestive heart failure. The most common cause of diastolic dysfunction in patients with 
aortic stenosis is left ventricular hypertrophy.  
In the study of Villari et al 46 diastolic dysfunction was defined either as abnormal 
relaxation, decreased diastolic filling or increased myocardial stiffness. Diastolic 
dysfunction was observed in approximately 50% of all patients with a normal systolic 
ejection performance, but was found in 95% of those with depressed systolic function. 
 Late after aortic valve replacement (up to 10 years) both diastolic stiffness and 
relaxation improve due to the regression of both muscular and collagen tissue. Thus, 
reversal of diastolic dysfunction in aortic stenosis takes years and is accompanied by a 
slow regression of interstitial fibrosis, whereas reversal of systolic dysfunction occurs 
more rapidly due to mechanical unloading, with a rapid decrease in muscle mass. 
Diastolic filling, however, remains unchanged after valve replacement, indicating that 
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this parameter is relatively insensitive to changes in diastolic function but is highly 
influenced by age, loading conditions and hypertrophy. Excessive hypertrophy is, 
however, associated with a significant increase in postoperative mortality51.             
Older studies have used catheterisation derived data for assessment of diastolic 
dysfunction9,10. More recent studies use MRI8, 2D and M mode echocardiographic 
variables1,10 for the assessment of diastolic dysfunction. This study is the first of its kind 
to assess the diastolic dysfunction with tissue doppler echocardiography and symptom 
correlation in patients with aortic stenosis.  
Hildo J. Lamb,  Hugo P et al8 studied diastolic function in patients with AS. They 
used MRI parameters like twisting and untwisting for assessment of diastolic 
dysfunction. They correlated their data well with catheterization findings. 
Villari et al and Lund et al46,51 used cardiac catheterization for measurement of 
LV diastolic dysfunction, they graded the diastolic dysfunction according to 
catheterization data and submitted the patients for surgery. They found that there was 
regression of diastolic dysfunction in those patients who underwent aortic valve 
replacement. 
Bech-Hanssen, Peter Gjertsson et al1 used two dimensional and M mode 
echocardiography to find out the aortic stenosis patients with LV diastolic dysfunction. 
They used routine diastolic grading for assessment of severity of diastolic dysfunction. 
They did not use the tissue doppler parameters for the identification of diastolic 
dysfunction. They found that patients with advanced diastolic dysfunction continue to be 
symptomatic and had more morbidity and mortality after aortic valve replacement. 
Kristensen et al10 also used two dimensional and M mode echocardiography for 
preoperative assessment of diastolic dysfunction in AS. They found that patients with 
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higher degree of diastolic dysfunction had poor prognosis even after aortic valve 
replacement. In this study tissue Doppler was not used. 
A recent study conducted at mayo clinic in patients with aortic stenosis by 
Grace.C et al4, found that E/Ea was directly correlated with pulmonary artery systolic 
pressure. In this study patients with other conditions producing diastolic dysfunction were 
not excluded. Patient with elevated E/Ea value were more symptomatic than with lower 
E/Ea values. Symptoms were not tested objectively by doing exercise testing. The study 
group consisted of patients with left ventricular systolic dysfunction also. They did not 
correlate the symptom to E/Ea values. 
In the presence of severe LV systolic dysfunction, increased E value and DT of 
less than 130 msec both correlate to elevated PCWP. But with normal LV systolic 
function both lose their correlation to PCWP.  
E/Ea may be used to identify the presence and severity of diastolic dysfunction. 
E/Ea ratio of more than fifteen correlates with pulmonary capillary pressure of more than 
20 mmHg. In the presence of severe LV systolic dysfunction, increased E value and DT 
of less than 130 msec both correlate to elevated PCWP. But with normal LV systolic 
function both lose their correlation to PCWP.  
E/Ea value is not modified by the presence of LV systolic dysfunction. E/Ea ratio 
is preload, afterload and heart rate independent index. So, it is more reliable even in 
circumstances which modify the above factors. 
This study demonstrates LV diastolic filling pressure, as represented by increased 
E/Ea ratio correlates well with the symptoms and inversely associated with six minute 
walk distance. Among all the diastolic indices Ea values and E/Ea ratio were found to be 
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statistically significant and consistently inversely associated with six minute walk 
distance.      
             In this study asymptomatic patients with severe AS with elevated E/Ea ratio had 
reduced six minute walk distance. It is evidenced from this study that patients with 
normal LV function and severe aortic stenosis developed increase in filling pressure 
(increased E/Ea ratio), even before the development of symptoms. It was proven by many 
studies that presence of higher degree of irreversible diastolic dysfunction may develop in 
individuals with asymptomatic severe aortic stenosis in the pre operative period and it is 
associated with reduced long term and short term mortality, if they were operated after 
the development of symptoms1. 
 This study demonstrates E/Ea as a single most reliable diastolic parameter to 
predict onset of symptoms and reduction in functional capacity in patients with aortic 
stenosis. This study undermines the importance of identifying the asymptomatic patients 
with aortic stenosis and elevated filling pressures.  
Aortic valve replacement in patients with asymptomatic but severe aortic stenosis 
is controversial. Patients with severe aortic stenosis have not been referred for valve 
replacement as long as they remain asymptomatic. However, there remains concern about 
the risk of irreversible myocardial damage or sudden death among such patients who do 
not undergo surgery. 
                    Higher degree of diastolic dysfunction is irreversible even after aortic valve 
replacement, so those asymptomatic patients should be identified at an early date, before 
the development of severe diastolic dysfunction1. Since our study group contains small 
number of asymptomatic individuals, it needs a large multicentre randomized trial to 
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decide whether the patients with elevated E/Ea value and asymptomatic severe aortic 
stenosis to be subjected for aortic valve replacement. 
Aortic valve replacement (AVR) is advised in symptomatic patients, presence LV 
dysfunction or concurrent intra cardiac surgeries. In the absence of above indications 
AVR is not coming under class1 indication. All other indications come under class IIb. 
So, it is frequent for patients with AS and diastolic dysfunction may go unoperated 
because of lack of symptoms or LV dysfunction. But this patient may develop higher 
degree of LV dysfunction which may not reverse after AVR. This population of patients 
with severe diastolic dysfunction may be benefitted by early aortic valve replacement. In 
this study asymptomatic patients with elevated E/Ea values have reduced six minute walk 
distance. So, they may be candidate for aortic valve replacement. 
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                                                             CONCLUSIONS 
 
1.  Diastolic dysfunction develops in patients with aortic stenosis even in the 
presence of normal left ventricular systolic function. 
2. E/Ea ratio is elevated in symptomatic patients with aortic stenosis. 
3. Among diastolic parameters increased E/Ea ratio correlates with severity 
of symptoms.  
4. E/Ea ratio has highly significant inverse correlation and Ea velocity has 
direct correlation with functional capacity. 
5. TDI derived E/Ea ratio could be an early marker for aortic valve 
replacement in asymptomatic patients with severe aortic stenosis.  
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                                            LIMITATIONS OF THE STUDY 
 
1. The number of patients included in this study is less. 
2. Our study population was highly selective and restricted to one 
geographical area. 
3. Since female sample size was smaller, significant difference between the 
two genders was not demonstrated. 
4. This study results  may be applicable  only in severe grades of AS 
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                                           GLOSSARY & ACRONYMS  
AS - Aortic stenosis 
BCAV - Bicuspid aortic valve 
CAD - Coronary artery disease 
LDL - Low density lipoprotein 
LV – Left ventricle 
TTE - Trans Thoracic Echocardiogram. 
MRI - Magnetic Resonance Imaging. 
LVEF - Left Ventricular Ejection Fraction.  
EDD – End Diastolic Diameter 
MPI – Myocardial Performance Index 
EF – Ejection Fraction 
ECG - Electrocardiography 
IVCT – Isovolumetric Contraction Time 
IVRT – Isovolumetric Relaxation Time 
TDI – Tissue Doppler Imaging 
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Ea – Early phase of diastolic myocardial velocity 
Aa – Late phase of diastolic myocardial velocity 
PCWP – pulmonary capillary wedge pressure 
LVEDP – left ventricular end diastolic pressure 
TVI – time velocity integral 
AVR – aortic valve replacement 
ACC – American college of cardiology 
AHA – American heart association 
6 MWD – six minute walk distance 
6MWT – six minute walk test 
 
MASTER CHART
    S.NO    NAME CD NO age sex Dx E A IVRT DT E/A Ea Aa E/Ea LA size PV  S/D MPI EF symptom 6MWD‐mt
1 Indirani   24367 45 F  Sev  84 137 116 266 0.6 4.29 10.8 19.5 4.1 1.54 0.78 61 Y 234
2 Valli  25212 69 F Sev  78.8 93.5 98 240 0.84 3.9 7.3 20.2 4.3 1.67 0.71 64 Y  187
3 Lailakumari  27008 41 F Sev 81 64 90 179 1.27 4.4 4.8 18.4  3.8 1.41 0.8 68 Y 280
4 Kesavan  36297 57 M Sev 83.6 89.6 102 228 0.93 5.45  8.29 15.3 3.7 1.28 0.68 63 Y  240
5 Elumalai  37558 42 M Mod  91.4 67 88 182 1.36 9.75 5.75 9.4 3.4 1.24 0.82 61 N 327
6 Elumalai  39114 49 M  Sev  86.4  74.5  79 195 1.16 6.53 9.94 13.2 4 1.31 0.56 59 Y 260
7 Perumal  24882 37  M Mod 71.4 69 91 166 1.03 9.02 9.2 7.9 3.7 1.7 0.78 70 N 370
8 Rajan  17895 58 M  Sev  102.1  67 76 152 1.52  5.8  8.8 17.6 4.2 0.7 0.91 58 Y 202
9 Shanmugam  19774 48 M  Sev  69 59.9  81 178 1.15 4.2  8.7 16.4 4.8 1.1 0.56 65 N 311
10 Manimegalai  40765 51  F Mod 82.8 79.3  86 192 1.04  8.21  9.5 10.1 3.5 0.99 0.70  59 N 412
11 Kaleel  36142 63 M Sev 78.7 92 120 256 0.86 4.1 9.6  19.2 5 0.81  0.89 63 Y  196
12 Ramesh  29555 32 M  Sev 76.1  97.4 98 270 0.78 6 7.8 12.7 3.6 1.2 0.57 66 N 376
13 Appavu  40123 47 M Mod  92.7 78 76 169 1.19 11.6 6.7 7.9 4.1 1.6 0.43 73 N 445
14 Kuppan  39607 59  M Mod 106.1 56 60 154 1.89  3.9  9.7 27.2 5.1 1.21 0.8 55 Y 207
15 Malaisamy  12085 62  M Sev 97.5 72.1 85 178 1.35  5.2 8.6 18.8  4.8 1.34 0.65 62 N 279
16 Radhabai    28956 71  F Sev  82.4 90.6 97 231 0.91  3.3 8.1 25 4.3 2.3 0.7 60 Y 260
17 Venkatesan  41034 55 M Sev 78.7 92.9 106 229 0.85 4.1 6.9  19.2  3.9 1.43 0.56 64 Y  156
18 Pitchaimani  32850 42  M Sev 78 130 121 269 0.6  6.3 7.9 12.3 2.9 0.87 0.4 66 N 378
19 Muthuraj  28461 49 M Sev 102.5 96.1 80 170 1.07  5.1 8.2 20.1 4.1 0.99 0.78 63 Y 141
20 Chandran  40281 57 M Sev 80.5 78.3 91 161 1.03  4.3 7.2 18.7 3.7 1.2 0.45 56 Y  234
21 Thangadurai  31398 52 M Sev 76.4 87.4 98 201 0.87 3.5 8.9 21.8 4.2 1.21 0.89 62 Y  187
22 Munian  16783 45 M Mod  93.6 78.4 78 172 1.19 12.6 9.8 7.4  2.7 1.72 0.35 70 N  469
23 Mariammal  23516 62 F Sev 76.3 10.1  97 189 0.75 4.1 6.4 18.6 3.8 1.1 0.89 55 Y 227
24 Veni  41827 59 F Sev  84  120.1 116 263 0.7 4.1 7.8 20.5  3.9 0.7 0.8 65 Y 254
25 Sundaramoorthy  27418 41  M Sev  91.7 78 85 163 1.12  3.6 5.9 25.5 4.9 1.3 0.56 55 Y 196
26 Sundaram  49122 54 M Sev  116  56 56 142 2.1 5.1 10.9 26.7  4.7 0.7 0.9 60 Y 206
27 Kalaiarasi  47278 47 F Mod 81.1 63.9 84 176 1.26 4.3 5.0  18.8  3 1.62 0.67 58 Y 251 
28 Vetrivel  11187 60 M Sev  92 67 73 180 1.4 5.5 8.3 16.7 4.2 1.4 0.75 61 Y 198
29 Vennila  32456 39 F Sev  84  89.5 98 230 0.94  4.7 6.6 17.9  4.8 0.8 0.94 59 Y 176
30 Pazhamalai  45329 53 M  Mod  91.1  59 63 151 1.54 10.7 9.7 8.5 3.7 1.4 0.4  76 N 387
31 Natarajan  24398 42 M Sev 74 97 90 210 0.76 3.4 7.9  21.8 4.6 2.1 0.81 57 Y 216
32 Sivakumar  19267 48 M Sev  83.9 40 99 138 2.1 4.1 8.5  20.4 4 0.7 0.9  56 Y 234
33 Chandrasekar  41362 59 M Sev 80.9  62.7 72 167 1.3 5.7 5.6 14.2 3.6 0.69 0.83 78 Y 287
34 Saraswathy  27130 64  F Sev 92.3 68.1  79 198 1.4 3.7 8 24.9 4.4 1.1 0.6 66  Y  178
35 Padmanaban  49621 45 M  Sev 77.2  56 92 201 1.36 4 6.3 19.3 3.2 1.7 0.89 55  Y 224
36 Rajeswari  31627 42  F Sev 71  62.5 84 154 1.13 3.4 7.4 20.1 4.8 1.76 0.73 64  Y 165
37 Shek sulaiman  25409 63 M  Mod 87.3  127 122 269 0.69 11 8.71 7.9 3.1 1.65 0.5 62 N 427
38 Thirumalai  42945 57 M Sev 85.6 135 113 248 0.63  4.1  10.8  20.9 4.4 1.65 0.8 66 Y  231
39 Selvi  17436 53 F Mod 92 66 86 175 1.39  12.4 7.2 7.4 2.6 1.9 0.91 60 N 492
40 Benjamin  24534 59 M  Sev  89.9 75 79 183 1.19 3.6 8.4 24.9 4.9 1.4 0.85 63 Y 187
